-
Signature
-
/s/ John E. Davis
-
Issuer symbol
-
AORT
-
Transactions as of
-
14 Nov 2025
-
Net transactions value
-
-$195,641
-
Form type
-
4
-
Filing time
-
18 Nov 2025, 13:03:12 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Davis John E |
Chief Commercial Officer |
1655 ROBERTS BLVD., NW, KENNESAW |
/s/ John E. Davis |
18 Nov 2025 |
0001653206 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AORT |
Common Stock |
Options Exercise |
$189,361 |
+6,393 |
+3.2% |
$29.62 |
205,235 |
14 Nov 2025 |
Direct |
F1 |
| transaction |
AORT |
Common Stock |
Sale |
$285,575 |
-6,393 |
-3.1% |
$44.67 |
198,842 |
14 Nov 2025 |
Direct |
F1 |
| transaction |
AORT |
Common Stock |
Options Exercise |
$189,390 |
+6,394 |
+3.2% |
$29.62 |
205,236 |
17 Nov 2025 |
Direct |
F1 |
| transaction |
AORT |
Common Stock |
Sale |
$288,817 |
-6,394 |
-3.1% |
$45.17 |
198,842 |
17 Nov 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AORT |
Stock Options (Right to buy) |
Options Exercise |
$0 |
-6,393 |
-100% |
$0.000000 |
0 |
14 Nov 2025 |
Common Stock |
6,393 |
$29.62 |
Direct |
F1, F2 |
| transaction |
AORT |
Stock Options (Right to buy) |
Options Exercise |
$0 |
-6,394 |
-100% |
$0.000000 |
0 |
17 Nov 2025 |
Common Stock |
6,394 |
$29.62 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: